Back to top
more

Elevance Health, Inc. (ELV)

(Real Time Quote from BATS)

$547.59 USD

547.59
103,522

+1.63 (0.30%)

Updated Aug 26, 2024 01:18 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value F Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 41% (148 out of 251)

Industry: Medical Services

Better trading starts here.

Zacks News

Cigna (CI) Unveils 2024 Expansion Plans, Eyes Membership Growth

Cigna (CI) declares the availability of a varied set of health plans across new counties in 2024. It, thereby, places intensified focus on growing its Medicare business.

Elevance Health (ELV) to Expand in 91 New Counties in 2024

Elevance Health (ELV) is set to enhance its product suite and expand to 91 counties in 2024, improving the overall health of people.

Elevance Health (ELV) Hits Pause on $2.5B BCBSLA Acquisition

Elevance Health (ELV) and BCBS Louisiana have opted to withdraw the acquisition application from the Louisiana Department of Insurance.

The Zacks Analyst Blog Highlights Alibaba Group, TotalEnergies, ConocoPhillips, Elevance Health and The Charles Schwab

Alibaba Group, TotalEnergies, ConocoPhillips, Elevance Health and The Charles Schwab are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Stock Reports for Alibaba, TotalEnergies, ConocoPhillips & Others

Today's Research Daily features new research reports on 16 major stocks, including Alibaba Group Holding Limited (BABA), TotalEnergies SE (TTE) and ConocoPhillips (COP).

Why Elevance Health (ELV) is a Top Value Stock for the Long-Term

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Elevance Health (ELV) Gains But Lags Market: What You Should Know

Elevance Health (ELV) closed at $449.26 in the latest trading session, marking a +0.11% move from the prior day.

Here's Why Investors are Retaining Elevance (ELV) Stock Now

Elevance's (ELV) focus on expanding the capabilities of the Carelon platform is likely to position the company for long-term growth.

Elevance Health (ELV) Gains As Market Dips: What You Should Know

In the latest trading session, Elevance Health (ELV) closed at $450.15, marking a +1.76% move from the previous day.

Elevance Health (ELV) Stock Moves 0.38%: What You Should Know

Elevance Health (ELV) closed the most recent trading day at $459.57, moving +0.38% from the previous trading session.

Medtronic's (MDT) Inceptiv Spinal Cord Stimulator Gets CE Mark

Medtronic's (MDT) Inceptiv SCS System is the first Medtronic SCS device to offer a closed-loop feature that senses each person's unique biological signals.

BrainsWay (BWAY) Expands Foothold in Taiwan With Deep TMS

The collaboration between BrainsWay (BWAY) and Unison Healthcare Group signifies a coordinated effort to enhance access and awareness of Deep TMS in Taiwan.

LabCorp (LH) Suffers From Lower COVID Test Sales, Macro Woes

Labcorp's (LH) Early Development Research Laboratories business continues to be constrained by NHP-related supply-chain issues.

Charles River (CRL) Collaborates With Fondazione Telethon

Charles River (CRL) is excited about Fondazione Telethon's collaboration to produce HQ plasmid DNA for the lentivirus used in ex vivo gene therapy developed by Fondazione Telethon.

Elevance Health (ELV) Stock Moves -0.84%: What You Should Know

In the latest trading session, Elevance Health (ELV) closed at $456, marking a -0.84% move from the previous day.

Here's Why You Should Retain Hologic (HOLX) Stock for Now

Investors are optimistic about Hologic (HOLX) on the expanded global installed base of more than 3,250 Panthers instruments, representing the catalyst for sustained growth.

Veeva Systems (VEEV) to Support Civica Rx Quality Control

Veeva Systems' (VEEV) Vault LIMS will streamline internal testing and manufacturing while promoting lead time adherence.

Thermo Fisher (TMO) Launches New Chromosomal Microarray

Thermo Fisher's (TMO) CytoScan HD Accel array can save labs weeks or even months by accelerating the time it takes to get findings from cytogenetic research.

Here's Why Investors Should Retain STERIS (STE) Stock for Now

Investors are optimistic about STERIS' (STE) successful integration of the recently-acquired business and raised guidance.

Here's Why You Should Invest in Align Technology (ALGN) Now

Investors are optimistic about Align Technology (ALGN), led by Invisalign portfolio expansion and raised guidance.

Here's Why You Should Invest in Penumbra (PEN) Stock for Now

Investors are upbeat about Penumbra (PEN) on Strong uptake following the launch of Lightning Flash, which accelerated top-line growth.

Why Is Elevance Health (ELV) Down 3.4% Since Last Earnings Report?

Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

The Zacks Analyst Blog Highlights Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services

Accenture, Elevance Health, Analog Devices, Monster Beverage and West Pharmaceutical Services are part of the Zacks top Analyst Blog.

Sheraz Mian headshot

Top Research Reports for Accenture, Elevance Health & Analog Devices

Today's Research Daily features new research reports on 16 major stocks, including Accenture plc (ACN), Elevance Health, Inc. (ELV) and Analog Devices, Inc. (ADI).